University College London (UCL)

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm (2022) Hageman SHJ, Mckay AJ, Ueda P, Gunn LH, Jernberg T, Hagstrom E, Bhatt DL, et al. Journal article Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? (2022) Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, et al. Journal article, Review article Time to evolve: predicting engineered T cell-associated toxicity with next-generation models (2022) Donnadieu E, Luu M, Alb M, Anliker B, Arcangeli S, Bonini C, De Angelis B, et al. Journal article, Review article Complications of Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis (2022) Zargaran D, Zoller F, Zargaran A, Rahman E, Woollard A, Weyrich T, Mosahebi A Journal article, Review article Correlation of Fc Receptor Polymorphisms with Pneumococcal Antibodies in Vaccinated Kidney Transplant Recipients (2022) Arnold M, Heinemann FM, Oesterreich S, Wilde B, Gackler A, Goldblatt D, Spriewald B, et al. Journal article Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study (2022) Kimura S, Toyoda K, Yoshimura S, Minematsu K, Yasaka M, Paciaroni M, Werring DJ, et al. Journal article Intercountry and intracountry variations in opinions of palliative care specialist physicians in Germany, Italy, Japan and UK about continuous use of sedatives: an international cross-sectional survey (2022) Morita T, Kawahara T, Stone P, Sykes N, Miccinesi G, Klein C, Stiel S, et al. Journal article Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial (2022) Waijer SW, Vart P, Cherney DZ, Chertow GM, Jongs N, Langkilde AM, Mann JFE, et al. Journal article Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data (2022) Schlaich M, Pietzsch JB, Mahfoud F, Wiliams B, Mancia G, Narkiewicz K, Ruilope L, et al. Conference contribution Beyond founder and truncting variants in TECPR2-associated disorder (2022) Neuser S, Brechmann B, Heimer G, Brosse I, Schubert S, O'Grady L, Zech M, et al. Conference contribution